nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study
|
Stefanutti, Claudia |
|
2019 |
13 |
4 |
p. 608-617 |
artikel |
2 |
Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials
|
Ferdinand, Keith C. |
|
2019 |
13 |
4 |
p. 586-593.e5 |
artikel |
3 |
Association between circadian preference and blood lipid levels using a 1:1:1 propensity score matching analysis
|
Kwon, Yu-Jin |
|
2019 |
13 |
4 |
p. 645-653.e2 |
artikel |
4 |
Association of baseline LDL-C with total and cardiovascular mortality in patients using proprotein convertase subtilisin-kexin type 9 inhibitors: A systematic review and meta-analysis
|
Khan, Safi U. |
|
2019 |
13 |
4 |
p. 538-549 |
artikel |
5 |
Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men
|
Takaeko, Yuji |
|
2019 |
13 |
4 |
p. 664-672.e1 |
artikel |
6 |
Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids
|
Faridi, Kamil F. |
|
2019 |
13 |
4 |
p. 634-644 |
artikel |
7 |
Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial
|
Lalwani, Narendra D. |
|
2019 |
13 |
4 |
p. 568-579 |
artikel |
8 |
Current trends in non–HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease
|
Vega, Gloria Lena |
|
2019 |
13 |
4 |
p. 563-567 |
artikel |
9 |
Editorial Board
|
|
|
2019 |
13 |
4 |
p. A1-A4 |
artikel |
10 |
Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association
|
Robinson, Jennifer G. |
|
2019 |
13 |
4 |
p. 525-537 |
artikel |
11 |
From the editor: Homeward bound?
|
Guyton, John R. |
|
2019 |
13 |
4 |
p. 509 |
artikel |
12 |
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus?
|
Browne, Richard W. |
|
2019 |
13 |
4 |
p. 654-663.e1 |
artikel |
13 |
Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy
|
Warden, Bruce A. |
|
2019 |
13 |
4 |
p. 580-585 |
artikel |
14 |
JCL Roundtable: Lipid clinic operations
|
Liebeskind, Ann |
|
2019 |
13 |
4 |
p. 511-521 |
artikel |
15 |
Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study
|
Blom, Dirk J. |
|
2019 |
13 |
4 |
p. 594-600 |
artikel |
16 |
LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia
|
Paquette, Martine |
|
2019 |
13 |
4 |
p. 627-633.e1 |
artikel |
17 |
News from the NLA
|
|
|
2019 |
13 |
4 |
p. 510 |
artikel |
18 |
Novel mutations of SAR1B gene in four children with chylomicron retention disease
|
Simone, Maria Luisa |
|
2019 |
13 |
4 |
p. 554-562 |
artikel |
19 |
Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey
|
Farnier, Michel |
|
2019 |
13 |
4 |
p. 601-607 |
artikel |
20 |
South Asian ancestry as a risk enhancer for ASCVD: Merits and challenges
|
Vijayaraghavan, Krishnaswami |
|
2019 |
13 |
4 |
p. 522-524 |
artikel |
21 |
Statin use in carnitine palmitoyltransferase II deficiency
|
Saeed, Anum |
|
2019 |
13 |
4 |
p. 550-553 |
artikel |
22 |
Table of Contents
|
|
|
2019 |
13 |
4 |
p. A5-A7 |
artikel |
23 |
The island of Gran Canaria: A genetic isolate for familial hypercholesterolemia
|
Sánchez-Hernández, Rosa M. |
|
2019 |
13 |
4 |
p. 618-626 |
artikel |